Argon & Co collaborated with a major industrial manufacturer to slash inventory levels by 30% (approx. €400m) to deal with a significant debt. By optimising capacity allocation and production planning, this manufacturer achieved a sizable inventory reduction without compromising delivery times or customer satisfaction. This represents a huge potential reduction in working capital requirements, freeing up funds to pay down debt and fuel future growth.
In partnership with Argon & Co, a pharmaceutical giant embarked on supply chain optimisation to unlock value while maintaining financial stability. By projecting inventory optimisation targets for each market and brand, this pharmaceutical company could reinvest freed-up capital (approx. €800m) into growth initiatives without compromising dividend distribution policies or credit ratings.
If you would like to find out more about what we do, please fill in your details below and we'll be in touch with you shortly.